Cong Zhou
- Cancer Research top 2%
- Cancer Genomics and Diagnostics 8
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers 9
- Cancer Cells and Metastasis 7
-
- Lung Cancer Treatments and Mutations 6
- Molecular Biology top 10%
- Epigenetics and DNA Methylation 22
- Cancer-related gene regulation 16
- RNA modifications and cancer 11
- Biotechnology top 10%
-
- Ovarian cancer diagnosis and treatment 6
- Co-authors
- Caroline DiveFiona BlackhallKaren MorrisMatthew KrebsAlison BackenRobert Szczepaniak‐SloaneLee LancashireLynsey Priest
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Cong Zhou
87 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 125
- Cancer Research 717
- Oncology 1.2k
- Pulmonary and Respiratory Medicine 442
- Molecular Biology 847
- Biotechnology 75
Countries citing papers authored by Cong Zhou
This map shows the geographic impact of Cong Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cong Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cong Zhou more than expected).
Fields of papers citing papers by Cong Zhou
This network shows the impact of papers produced by Cong Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cong Zhou. The network helps show where Cong Zhou may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Cong Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2023 | 5 | |
| 3 | 2022 | 14 | |
| 4 | The Value of Serum miR-139-3p Expression Level in Predicting Postoperative Survival of Colon Cancer Patients | 2022 | 2 |
| 5 | 2022 | 11 | |
| 6 | 2022 | 4 | |
| 7 | 2022 | 5 | |
| 8 | 2021 | 16 | |
| 9 | 2021 | 20 | |
| 10 | 2021 | 8 | |
| 11 | 2021 | 16 | |
| 12 | 2019 | 21 | |
| 13 | 2019 | 43 | |
| 14 | 2019 | 2 | |
| 15 | 2018 | 20 | |
| 16 | 2018 | 3 | |
| 17 | 2014 | 52 | |
| 18 | 2013 | 31 | |
| 19 | 2012 | 107 | |
| 20 | 2011 | 11 |
About Cong Zhou
Cong Zhou is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 87 papers that have together received 2.2k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (22 papers), Cancer-related gene regulation (16 papers), RNA modifications and cancer (11 papers), Cancer Immunotherapy and Biomarkers (9 papers), Cancer Genomics and Diagnostics (8 papers), Cancer Cells and Metastasis (7 papers), Ovarian cancer diagnosis and treatment (6 papers) and Lung Cancer Treatments and Mutations (6 papers). The work is most often cited by research in Cancer Research (717 citations), Oncology (1.2k citations) and Pulmonary and Respiratory Medicine (442 citations). Cong Zhou has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Caroline Dive, Fiona Blackhall, Karen Morris, Matthew Krebs, Alison Backen, Robert Szczepaniak‐Sloane, Lee Lancashire, Lynsey Priest, R Swain and Alastair Greystoke. Their work appears in journals such as BMC Cancer, Journal of Clinical Oncology, ESMO Open, Scientific Reports and Journal of Thoracic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.